🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, drug lev...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix
Start Date
2023-12-29
Trial ID
NCT06090539
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of CC-99282...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-01-29
Trial ID
NCT06209619
This phase II trial tests the effectiveness of golcadomide and rituximab as...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-04-02
Trial ID
NCT06834373
The purpose of this study is to assess the efficacy and safety of golcadomi...
Status
Active Not Recruiting
Location
Local Institution - 0152
Start Date
2024-08-30
Trial ID
NCT06425302
Treatments Being Tested
Prospective, multicenter, single arm, phase II study, to evaluate the effic...
Status
Recruiting
Location
AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria - SCDU Ematologia
Start Date
2025-04-09
Trial ID
NCT06835530
Treatments Being Tested
This phase I/II trial tests the safety, side effects, best dose and effecti...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2026-12-21
Trial ID
NCT07578077
First line treatment with combination rituximab and golcadomide with, or wi...
Status
Active Not Recruiting
Location
Grampians Health
Start Date
2023-08-31
Trial ID
NCT05788081
Treatments Being Tested
The purpose of this study is to compare the effectiveness and safety of gol...
Status
Active Not Recruiting
Location
Local Institution - 0014
Start Date
2024-06-19
Trial ID
NCT06356129
Treatments Being Tested
The study is designed as a multicenter, randomized, open label Phase 3 stud...
Status
Recruiting
Location
Local Institution - 0225
Start Date
2025-07-28
Trial ID
NCT06911502